19.500
−2,50%
2026-10-14
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +13.6% | +15.3% | 3 / 3 | +11.7% | -1.88 pp | +0.09 pp | +17.1% | 0.20 | 9.36 | 352 | +11,7% | 19,5 | +13,6% | 9.36 | 11.53 | −18,8% |
| Pts | 0 | 0 | 12 | 4 | 4 | 8 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 19.500 (close price on 2026-10-14)EPS (TTM): 2.084
Financial charts
1.Revenue & growth
VND bn352Q2/26
1.Revenue & growth
VND bn352Q2/26
2.Profit & growth
VND bn19,5Q2/26
3.Profit mix (Penman)
VND bn86,3Q2/26
4.Margins & cost structure
%20.8%Q2/26
5.Returns & cash cycle
% · days17.1%Q2/26
6.Earnings quality & cash
VND bn215Q2/26
7.Asset structure
VND bn612Q2/26
8.Funding & debt health
VND bn · times612Q2/26
9.Revenue backlog
VND bn0,79Q2/26
10.Valuation
times · %9,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %591Q2/26
Adjusted EPS growth, latest quarter
13.6%
Average adjusted EPS growth, 3 quarters
15.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26